Ginzburg announced the deadline for the new Sputnik to enter civilian circulation

Clinical trials of the updated COVID-19 vaccine “Sputnik Light” have been completed, and already in the first ten days of December it can go into civilian circulation. This was announced by the head of the Center. Gamaleya (developer of Sputnik V) Alexander Ginzburg in a conversation with RIA Novosti.

“If everything goes as we agreed with the Ministry of Health in terms of permitting issues, then, indeed, in the first ten days (December 10–15) Sputnik Light will be in civilian circulation,” he said.

The remaining vaccine options, including Sputnik V and the children's version, will arrive at medical institutions later.

To speed up the process, the Ministry of Health allowed the center to simultaneously increase the required volume of vaccines and write a report on the results of clinical trials, Gunzburg added. According to him, this will allow the vaccine batches (checked according to the department’s documentation) to be put into civilian circulation at the time of registration of the drug and not have to wait another two months.

The head of the Gamaleya center explained that after the virus changed antigenically, a change in the vaccine was also required. The lethality of the coronavirus has decreased, but at the same time its infectiousness has increased, he noted.

At the end of October, Ginzburg said that Sputnik V had ceased to protect against new strains of COVID-19. Since mid-summer 2022, when coronavirus variants Omicron 1, 2 and 3 emerged, vaccine effectiveness has dropped eightfold. When options 4 and 5 appeared, the efficiency dropped by 20 times. The drug is completely powerless against new variants.

RBC Pro development program Successful negotiations: a new skill What tricks of legendary scammers will be useful to you during negotiations “I’m also a professional”: 10 tough tricks of manipulators in negotiations Questions that control negotiations: how to ask and what to expect in response Successful negotiations Good scenario: what prevents you from taking control of your destiny How to deal with different types of negotiators

In the same month, Deputy Mayor of Moscow for Social Development Anastasia Rakova spoke about the start of clinical trials of the Sputnik V and single-component Sputnik Light vaccines, adapted for the new strain of coronavirus XBB-1.

The operational headquarters reported that from November 6 to November 12, the incidence of COVID increased by 22.8%, an increase was noted in 70 regions of Russia. The head of Rospotrebnadzor Anna Popova noted on November 8 that a double increase in the incidence of COVID was recorded compared to a month ago. She said that this was regarded as the beginning of an epidemic.